Vivos to buy 50% stake in SOD Sciences’ pseudohypoxia test
Vivos Therapeutics has entered into a definitive agreement for an 11% fully diluted equity interest in SOD Sciences along with a 50% undivided co-ownership stake in its pseudohypoxia early-warning diagnostic test.
The post Vivos to buy 50% stake in SOD Sciences’ pseudohypoxia test appeared first on Medical Device Network .